Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE

CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE

Standard Dose
800MG;10MG;165MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE is listed in Drugs@FDA under application 204782 (ANDA).

Marketing status: Discontinued Active ingredient CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE Form and strength TABLET, CHEWABLE;ORAL - 800MG;10MG;165MG Sponsor PERRIGO R AND D Submission history Latest submission status date: 2016-08-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE is listed in Drugs@FDA under application 204782 (ANDA). Marketing status: Discontinued Active ingredient CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE Form and strength TABLET, CHEWABLE;ORAL - 800MG;10MG;165MG Sponsor PERRIGO R AND D Submission history Latest submission status date: 2016-08-29 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE (CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE) | Drug Monograph | MedicHelpline